Report Detail
Global (United States, European Union and China) Type 1 Diabetes (T1D) Market Research Report 2019-2025
- RnM3579836 |
- 08 July, 2019 |
- Global |
- 111 Pages |
- QYResearch |
- Pharma & Healthcare
Type 1 diabetes (T1D) is an autoimmune disease that occurs when a person’s pancreas stops producing insulin, the hormone that controls blood-sugar levels. T1D develops when the insulin-producing pancreatic beta cells are mistakenly destroyed by the body’s immune system. The cause of this attack is still being researched, however scientists believe the cause may have genetic and environmental components.
Sedentary lifestyle, unhealthy diet, lack of exercise and increasing prevalence of diabetes are key driver for Type 1 Diabetes (T1D) market. Insulin therapy is very much essential in the patients who have type 1 diabetes. Rising launch of the novel insulin formulations along with several adjunct therapies will positively impact the insulin acceptance. On the other hand, this chronic disorder poses a significant economic impact owing to the increasing cost of insulin coupled with other conditions such as cardiac disorders, kidney disease among others. While insulin therapy keeps people with T1D alive and can help keep blood-glucose levels within recommended range, it is not a cure, nor does it prevent the possibility of T1D’s serious effects. Although T1D is a serious and challenging disease, long-term management options continue to evolve, allowing those with T1D to have full and active lives. Asia Pacific region recorded the highest growth rate over the forecast period owing to the increasingly sedentary lifestyles, obese population, and improper food habits. North America accounted for more than 50% of the total market share over the forecast period.
In 2019, the market size of Type 1 Diabetes (T1D) is 1960 million US$ and it will reach 2810 million US$ in 2025, growing at a CAGR of 4.6% from 2019; while in China, the market size is valued at xx million US$ and will increase to xx million US$ in 2025, with a CAGR of xx% during forecast period.
In this report, 2018 has been considered as the base year and 2019 to 2025 as the forecast period to estimate the market size for Type 1 Diabetes (T1D).
This report studies the global market size of Type 1 Diabetes (T1D), especially focuses on the key regions like United States, European Union, China, and other regions (Japan, Korea, India and Southeast Asia).
This study presents the Type 1 Diabetes (T1D) sales volume, revenue, market share and growth rate for each key company, and also covers the breakdown data (sales, revenue and market share) by regions, type and applications. history breakdown data from 2014 to 2019, and forecast to 2025.
For top companies in United States, European Union and China, this report investigates and analyzes the production, value, price, market share and growth rate for the top manufacturers, key data from 2014 to 2019.
In global market, the following companies are covered:
Novo Nordisk
Sanofi
Eli Lilly
Merck
Boehringer Ingelheim
Samsung Bioepis
Biocon
Astellas
Janssen
Bristol-Myers Squibb
Lexicon
Sanofi
Market Segment by Product Type
Rapid Acting Insulin Analogs
Long Acting Insulin Analogs
Premix Insulin Analogs
Market Segment by Application
Children
Adults
Key Regions split in this report: breakdown data for each region.
United States
China
European Union
Rest of World (Japan, Korea, India and Southeast Asia)
The study objectives are:
To analyze and research the Type 1 Diabetes (T1D) status and future forecast in United States, European Union and China, involving sales, value (revenue), growth rate (CAGR), market share, historical and forecast.
To present the key Type 1 Diabetes (T1D) manufacturers, presenting the sales, revenue, market share, and recent development for key players.
To split the breakdown data by regions, type, companies and applications
To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints and risks.
To identify significant trends, drivers, influence factors in global and regions
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market
In this study, the years considered to estimate the market size of Type 1 Diabetes (T1D) are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
Table of Contents
1 Report Overview
- 1.1 Study Scope
- 1.2 Major Manufacturers Covered in This Report
- 1.3 Market Segment by Type
- 1.3.1 Global Type 1 Diabetes (T1D) Market Size Growth Rate by Type (2019-2025)
- 1.3.2 Rapid Acting Insulin Analogs
- 1.3.3 Long Acting Insulin Analogs
- 1.3.4 Premix Insulin Analogs
- 1.4 Market Segment by Application
- 1.4.1 Global Type 1 Diabetes (T1D) Market Share by Application (2019-2025)
- 1.4.2 Children
- 1.4.3 Adults
- 1.5 Study Objectives
- 1.6 Years Considered
2 Global Growth Trends
- 2.1 Global Type 1 Diabetes (T1D) Market Size
- 2.1.1 Global Type 1 Diabetes (T1D) Revenue 2014-2025
- 2.1.2 Global Type 1 Diabetes (T1D) Sales 2014-2025
- 2.2 Type 1 Diabetes (T1D) Growth Rate by Regions
- 2.2.1 Global Type 1 Diabetes (T1D) Sales by Regions 2014-2019
- 2.2.2 Global Type 1 Diabetes (T1D) Revenue by Regions 2014-2019
- 2.3 Industry Trends
- 2.3.1 Market Top Trends
- 2.3.2 Market Drivers
3 Market Share by Manufacturers
- 3.1 Type 1 Diabetes (T1D) Sales by Manufacturers
- 3.1.1 Type 1 Diabetes (T1D) Sales by Manufacturers 2014-2019
- 3.1.2 Type 1 Diabetes (T1D) Sales Market Share by Manufacturers 2014-2019
- 3.2 Revenue by Manufacturers
- 3.2.1 Type 1 Diabetes (T1D) Revenue by Manufacturers (2014-2019)
- 3.2.2 Type 1 Diabetes (T1D) Revenue Share by Manufacturers (2014-2019)
- 3.2.3 Global Type 1 Diabetes (T1D) Market Concentration Ratio (CR5 and HHI)
- 3.3 Type 1 Diabetes (T1D) Price by Manufacturers
- 3.4 Key Manufacturers Type 1 Diabetes (T1D) Plants/Factories Distribution and Area Served
- 3.5 Date of Key Manufacturers Enter into Type 1 Diabetes (T1D) Market
- 3.6 Key Manufacturers Type 1 Diabetes (T1D) Product Offered
- 3.7 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
- 4.1 Sales and Revenue for Each Type
- 4.1.1 Rapid Acting Insulin Analogs Sales and Revenue (2014-2019)
- 4.1.2 Long Acting Insulin Analogs Sales and Revenue (2014-2019)
- 4.1.3 Premix Insulin Analogs Sales and Revenue (2014-2019)
- 4.2 Global Type 1 Diabetes (T1D) Sales Market Share by Type
- 4.3 Global Type 1 Diabetes (T1D) Revenue Market Share by Type
- 4.4 Type 1 Diabetes (T1D) Price by Type
5 Market Size by Application
- 5.1 Overview
- 5.2 Global Type 1 Diabetes (T1D) Sales by Application
6 United States
- 6.1 United States Type 1 Diabetes (T1D) Breakdown Data by Company
- 6.2 United States Type 1 Diabetes (T1D) Breakdown Data by Type
- 6.3 United States Type 1 Diabetes (T1D) Breakdown Data by Application
7 European Union
- 7.1 European Union Type 1 Diabetes (T1D) Breakdown Data by Company
- 7.2 European Union Type 1 Diabetes (T1D) Breakdown Data by Type
- 7.3 European Union Type 1 Diabetes (T1D) Breakdown Data by Application
8 China
- 8.1 China Type 1 Diabetes (T1D) Breakdown Data by Company
- 8.2 China Type 1 Diabetes (T1D) Breakdown Data by Type
- 8.3 China Type 1 Diabetes (T1D) Breakdown Data by Application
9 Rest of World
- 9.1 Rest of World Type 1 Diabetes (T1D) Breakdown Data by Company
- 9.2 Rest of World Type 1 Diabetes (T1D) Breakdown Data by Type
- 9.3 Rest of World Type 1 Diabetes (T1D) Breakdown Data by Application
- 9.4 Rest of World Type 1 Diabetes (T1D) Breakdown Data by Countries
- 9.4.1 Rest of World Type 1 Diabetes (T1D) Sales by Countries
- 9.4.2 Rest of World Type 1 Diabetes (T1D) Revenue by Countries
- 9.4.3 Japan
- 9.4.4 Korea
- 9.4.5 India
- 9.4.6 Southeast Asia
10 Company Profiles
- 10.1 Novo Nordisk
- 10.1.1 Novo Nordisk Company Details
- 10.1.2 Company Description and Business Overview
- 10.1.3 Sales, Revenue and Market Share of Type 1 Diabetes (T1D)
- 10.1.4 Type 1 Diabetes (T1D) Product Introduction
- 10.1.5 Novo Nordisk Recent Development
- 10.2 Sanofi
- 10.2.1 Sanofi Company Details
- 10.2.2 Company Description and Business Overview
- 10.2.3 Sales, Revenue and Market Share of Type 1 Diabetes (T1D)
- 10.2.4 Type 1 Diabetes (T1D) Product Introduction
- 10.2.5 Sanofi Recent Development
- 10.3 Eli Lilly
- 10.3.1 Eli Lilly Company Details
- 10.3.2 Company Description and Business Overview
- 10.3.3 Sales, Revenue and Market Share of Type 1 Diabetes (T1D)
- 10.3.4 Type 1 Diabetes (T1D) Product Introduction
- 10.3.5 Eli Lilly Recent Development
- 10.4 Merck
- 10.4.1 Merck Company Details
- 10.4.2 Company Description and Business Overview
- 10.4.3 Sales, Revenue and Market Share of Type 1 Diabetes (T1D)
- 10.4.4 Type 1 Diabetes (T1D) Product Introduction
- 10.4.5 Merck Recent Development
- 10.5 Boehringer Ingelheim
- 10.5.1 Boehringer Ingelheim Company Details
- 10.5.2 Company Description and Business Overview
- 10.5.3 Sales, Revenue and Market Share of Type 1 Diabetes (T1D)
- 10.5.4 Type 1 Diabetes (T1D) Product Introduction
- 10.5.5 Boehringer Ingelheim Recent Development
- 10.6 Samsung Bioepis
- 10.6.1 Samsung Bioepis Company Details
- 10.6.2 Company Description and Business Overview
- 10.6.3 Sales, Revenue and Market Share of Type 1 Diabetes (T1D)
- 10.6.4 Type 1 Diabetes (T1D) Product Introduction
- 10.6.5 Samsung Bioepis Recent Development
- 10.7 Biocon
- 10.7.1 Biocon Company Details
- 10.7.2 Company Description and Business Overview
- 10.7.3 Sales, Revenue and Market Share of Type 1 Diabetes (T1D)
- 10.7.4 Type 1 Diabetes (T1D) Product Introduction
- 10.7.5 Biocon Recent Development
- 10.8 Astellas
- 10.8.1 Astellas Company Details
- 10.8.2 Company Description and Business Overview
- 10.8.3 Sales, Revenue and Market Share of Type 1 Diabetes (T1D)
- 10.8.4 Type 1 Diabetes (T1D) Product Introduction
- 10.8.5 Astellas Recent Development
- 10.9 Janssen
- 10.9.1 Janssen Company Details
- 10.9.2 Company Description and Business Overview
- 10.9.3 Sales, Revenue and Market Share of Type 1 Diabetes (T1D)
- 10.9.4 Type 1 Diabetes (T1D) Product Introduction
- 10.9.5 Janssen Recent Development
- 10.10 Bristol-Myers Squibb
- 10.10.1 Bristol-Myers Squibb Company Details
- 10.10.2 Company Description and Business Overview
- 10.10.3 Sales, Revenue and Market Share of Type 1 Diabetes (T1D)
- 10.10.4 Type 1 Diabetes (T1D) Product Introduction
- 10.10.5 Bristol-Myers Squibb Recent Development
- 10.11 Lexicon
- 10.12 Sanofi
11 Value Chain and Sales Channels Analysis
- 11.1 Value Chain Analysis
- 11.2 Sales Channels Analysis
- 11.2.1 Type 1 Diabetes (T1D) Sales Channels
- 11.2.2 Type 1 Diabetes (T1D) Distributors
- 11.3 Type 1 Diabetes (T1D) Customers
12 Market Forecast
- 12.1 Global Type 1 Diabetes (T1D) Sales and Revenue Forecast 2019-2025
- 12.2 Global Type 1 Diabetes (T1D) Sales Forecast by Type
- 12.3 Global Type 1 Diabetes (T1D) Sales Forecast by Application
- 12.4 Type 1 Diabetes (T1D) Forecast by Regions
- 12.4.1 Global Type 1 Diabetes (T1D) Sales Forecast by Regions 2019-2025
- 12.4.2 Global Type 1 Diabetes (T1D) Revenue Forecast by Regions 2019-2025
- 12.5 United States Market Forecast
- 12.6 European Union Market Forecast
- 12.7 China Market Forecast
- 12.8 Rest of World
- 12.8.1 Japan
- 12.8.2 Korea
- 12.8.3 India
13 Research Findings and Conclusion
14 Appendix
- 14.1 Research Methodology
- 14.1.1 Methodology/Research Approach
- 14.1.1.1 Research Programs/Design
- 14.1.1.2 Market Size Estimation
- 14.1.1.3 Market Breakdown and Data Triangulation
- 14.1.2 Data Source
- 14.1.2.1 Secondary Sources
- 14.1.2.2 Primary Sources
- 14.1.1 Methodology/Research Approach
- 14.2 Author Details
Summary:
Get latest Market Research Reports on Type 1 Diabetes (T1D). Industry analysis & Market Report on Type 1 Diabetes (T1D) is a syndicated market report, published as Global (United States, European Union and China) Type 1 Diabetes (T1D) Market Research Report 2019-2025. It is complete Research Study and Industry Analysis of Type 1 Diabetes (T1D) market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
